US Stock MarketDetailed Quotes

MBRX Moleculin Biotech

Watchlist
  • 1.6700
  • -0.1400-7.73%
Close Dec 20 16:00 ET
5.33MMarket Cap-0.14P/E (TTM)

About Moleculin Biotech Company

Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses. The company was founded by Walter V. Klemp, Donald H. Picker, and Waldemar Priebe on July 28, 2015 and is headquartered in Houston, TX.

Company Profile

SymbolMBRX
Company NameMoleculin Biotech
Listing DateJun 2, 2016
Issue Price6.00
Founded2015
CEOMr. Walter V. Klemp
MarketNASDAQ
Employees18
Fiscal Year Ends12-31
Address5300 Memorial Drive,Suite 950
CityHouston
ProvinceTexas
CountryUnited States of America
Zip Code77007
Phone1-713-300-5160

Company Executives

  • Name
  • Position
  • Salary
  • Walter V. Klemp
  • Chairman of the Board, President and Chief Executive Officer
  • 1.41M
  • Jonathan P. Foster
  • Chief Financial Officer, Executive Vice President and Principal Accounting Officer
  • 840.64K
  • Dr. Donald H. Picker, PhD
  • Chief Scientific Officer
  • 599.11K
  • Robert E. George
  • Independent Director
  • 74.90K
  • Elizabeth A. Cermak
  • Independent Director
  • 63.52K
  • John M. Climaco, Esq.
  • Lead Independent Director
  • 81.05K
  • Dr. Joy Yan, M.D.,PhD
  • Independent Director
  • 47.15K
  • Michael D. Cannon
  • Independent Director
  • 68.52K
Heat List
US
Overall
Symbol
Price
% Chg

No Data